The enhancement of Tetrandrine to gemcitabine-resistant PANC-1 cytochemical sensitivity involves the promotion of PI3K/Akt/mTOR-mediated apoptosis and AMPK-regulated autophagy

Oridonin overcomes the gemcitabine resistant PANC-1/Gem cells by regulating GST pi and LRP/1 ERK/JNK signalling

(2019) Bili Wang et al.   OncoTargets and Therapy

Tetrandrine and cepharanthine induce apoptosis through caspase cascade regulation, cell cycle arrest, MAPK activation and PI3K/Akt/mTOR signal modification in glucocorticoid resistant human leukemia Jurkat T cells

(2019) Wencheng Xu et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Tetrandrine inhibits deregulated cell cycle in pancreatic cancer cells: Differential regulation of p21 Cip1/Waf1 , p27 Kip1 and cyclin D1

(2018) Karnika Singh et al.   CANCER LETTERS

USP9X inhibition improves gemcitabine sensitivity in pancreatic cancer by inhibiting autophagy

(2018) Tao Ma et al.   CANCER LETTERS

Therapeutic strategies involving survivin inhibition in cancer

(2018) David Martínez‐García et al.   MEDICINAL RESEARCH REVIEWS

Targeting surface nucleolin induces autophagy-dependent cell death in pancreatic cancer via AMPK activation

(2018) Cheng Xu et al.   ONCOGENE

Synergistic cytotoxic effects of arsenite and tetrandrine in human breast cancer cell line MCF-7

(2017) Mingjiang Yao et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Autophagy induction enhances tetrandrine-induced apoptosis via the AMPK/mTOR pathway in human bladder cancer cells

(2017) Bo Kou et al.   ONCOLOGY REPORTS

Tetrandrine, a Chinese plant-derived alkaloid, is a potential candidate for cancer chemotherapy

(2016) Ting Liu et al.   Oncotarget

Gemcitabine resistance in pancreatic ductal adenocarcinoma

(2015) Yoav Binenbaum et al.   DRUG RESISTANCE UPDATES

Broad targeting of resistance to apoptosis in cancer

(2015) Ramzi M. Mohammad et al.   SEMINARS IN CANCER BIOLOGY

Pharmacodynamic modeling of cell cycle and apoptotic effects of gemcitabine on pancreatic adenocarcinoma cells

(2013) Salaheldin S. Hamed et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Knockdown of autophagy-related gene BECLIN1 promotes cell growth and inhibits apoptosis in the A549 human lung cancer cell line

(2013) WENYU WANG et al.   Molecular Medicine Reports

Tetrandrine inhibits hepatocellular carcinoma cell growth through the caspase pathway and G2/M phase

(2013) VIVIAN W.L. YU et al.   ONCOLOGY REPORTS

The Potential of Tetrandrine Against Gliomas

(2012) Yun Chen et al.   Anti-Cancer Agents in Medicinal Chemistry

Core signaling pathways of survival/death in autophagy-related cancer networks

(2011) Shu-ya Wang et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

The AMPK-FoxO3A axis as a target for cancer treatment

(2010) Fulvio Chiacchiera et al.   CELL CYCLE

Triptolide Induces Cell Death in Pancreatic Cancer Cells by Apoptotic and Autophagic Pathways

(2010) Nameeta Mujumdar et al.   GASTROENTEROLOGY

Tetrandrine induces apoptosis by activating reactive oxygen species and repressing Akt activity in human hepatocellular carcinoma

(2010) Chaoyang Liu et al.   INTERNATIONAL JOURNAL OF CANCER

Tetrandrine Inhibits Wnt/ -Catenin Signaling and Suppresses Tumor Growth of Human Colorectal Cancer

(2010) B.-C. He et al.   MOLECULAR PHARMACOLOGY

Targeting the PI3K–AKT–mTOR pathway: progress, pitfalls, and promises

(2008) Timothy A Yap et al.   CURRENT OPINION IN PHARMACOLOGY

Drug discovery approaches targeting the PI3K/Akt pathway in cancer

(2008) C Garcia-Echeverria et al.   ONCOGENE